Therefore, this study documents a novel ccRCC regulatory mechanism involving PEBP1P2 and provides a new potential therapeutic strategy to overcome ccRCC metastasis formation (Fig. 6). The gene discussed is PEBP1P2; the disease is nonpapillary renal cell carcinoma.